December 26, 2024 - 22:53

In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after the Marshall Fire outside Boulder, Colorado. The devastating wildfire, which occurred in late 2021, not only destroyed numerous homes but also left lingering health risks associated with smoke exposure.
The study highlights that individuals who returned to their residences may continue to face respiratory issues, cardiovascular problems, and other health complications long after the flames have been extinguished. Researchers found that even three years post-fire, the air quality in the affected areas had not fully recovered, and the residual smoke particles remained a concern for residents.
Participants reported symptoms such as coughing, shortness of breath, and exacerbated allergies, indicating a pressing need for public health interventions. The findings underscore the importance of ongoing monitoring and support for communities recovering from wildfires, emphasizing that the impact of such disasters can extend well beyond the immediate aftermath.
February 22, 2026 - 01:06
6 Things You Should Never Add to Your TeaTea is celebrated worldwide as a healthy beverage, linked to improved heart health and longevity. However, the benefits of this ancient drink can be easily diminished by common additions to your...
February 21, 2026 - 02:06
Justice Department Accuses OhioHealth of Restricting Patient Choice and Inflating CostsThe U.S. Department of Justice has filed a significant civil antitrust lawsuit against OhioHealth, alleging the hospital system illegally consolidated power to block patient access to more...
February 20, 2026 - 08:06
DPS school board votes to keep Kaiser health insurance for at least a yearIn a move ensuring continuity for thousands of staff members, the Denver Public Schools (DPS) Board of Education has voted to retain Kaiser Permanente as a health insurance provider for district...
February 19, 2026 - 21:56
Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and ChinaCommissioner Marty Makary is steering the U.S. Food and Drug Administration during a period of significant internal and external pressure. The agency faces operational challenges stemming from...